BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35218137)

  • 21. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
    Matsunaka T; Goi T; Kurebayashi H; Morikawa M; Okazawa H; Tsujikawa T
    Oncology; 2024; 102(2):99-106. PubMed ID: 37562361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of pre-operative MRI-detected extramural vascular invasion in the treatment of rectal carcinoma].
    Hemmelová B; Bohatá Š; Kyclová J; Kala Z; Penka I
    Rozhl Chir; 2018; 97(4):172-175. PubMed ID: 29726263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
    Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
    Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
    Marjasuo ST; Lehtimäki TE; Koskenvuo LE; Lepistö AH
    Eur J Surg Oncol; 2024 Jun; 50(6):108337. PubMed ID: 38657373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of a Staging System for Sigmoid Colon Cancer Based on Tumor Deposits and Extramural Venous Invasion on Computed Tomography.
    D'Souza N; Shaw A; Lord A; Balyasnikova S; Abulafi M; Tekkis P; Brown G
    JAMA Netw Open; 2019 Dec; 2(12):e1916987. PubMed ID: 31808924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of MRI-detected extramural venous invasion in rectal cancer.
    Tripathi P; Rao SX; Zeng MS
    J Dig Dis; 2017 Jan; 18(1):2-12. PubMed ID: 28009094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI features of signet ring rectal cancer.
    Suthar M; Baheti AD; Ankathi SK; Choudhari A; Haria PD; Engineer R; Ostwal V; Ramadwar MS; Desouza A; Saklani A
    Abdom Radiol (NY); 2021 Dec; 46(12):5536-5549. PubMed ID: 34427742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer.
    Guner OS; Tumay LV
    Asian J Surg; 2021 Jun; 44(6):841-847. PubMed ID: 33573925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary value of pre-treatment apparent diffusion coefficient in rectal cancer for predicting tumor recurrence.
    Moon SJ; Cho SH; Kim GC; Kim WH; Kim HJ; Shin KM; Lee SM; Park JS; Choi GS; Kim SH
    Abdom Radiol (NY); 2016 Jul; 41(7):1237-44. PubMed ID: 26830420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of extramural venous invasion and lateral lymph node size detected with magnetic resonance imaging is a reliable biomarker for lateral lymph node metastasis in patients with rectal cancer.
    Abe T; Yasui M; Imamura H; Matsuda C; Nishimura J; Haraguchi N; Nakai N; Wada H; Takahashi H; Omori T; Miyata H; Ohue M
    World J Surg Oncol; 2022 Jan; 20(1):5. PubMed ID: 34986842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.
    Gu C; Yang X; Zhang X; Zheng E; Deng X; Hu T; Wu Q; Bi L; Wu B; Su M; Wang Z
    Sci Rep; 2019 Aug; 9(1):12523. PubMed ID: 31467313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of extramural venous invasion detected by contrast-enhanced CT colonography in colon cancer.
    Kato T; Tsukamoto S; Miyake M; Kudose Y; Takamizawa Y; Moritani K; Daiko H; Kanemitsu Y
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38242576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative computed tomography assessment of circumferential resection margin in retroperitonealized colon cancer predicts disease-free survival.
    Seo N; Lim JS; Chung T; Lee JM; Min BS; Kim MJ
    Eur Radiol; 2023 Apr; 33(4):2757-2767. PubMed ID: 36355197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications.
    Ale Ali H; Kirsch R; Razaz S; Jhaveri A; Thipphavong S; Kennedy ED; Jhaveri KS
    Abdom Radiol (NY); 2019 Jan; 44(1):1-10. PubMed ID: 29967984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer.
    Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C
    Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perineural Invasion Is Associated with Poor Survival after Preoperative Chemoradiation Therapy for Advanced Lower Rectal Cancer.
    Yokoyama S; Matsuda K; Watanabe T; Mitani Y; Ieda J; Iwamoto H; Hotta T; Takifuji K; Yamaue H
    Dig Surg; 2017; 34(5):387-393. PubMed ID: 28099961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.
    Kennedy ED; Simunovic M; Jhaveri K; Kirsch R; Brierley J; Drolet S; Brown C; Vos PM; Xiong W; MacLean T; Kanthan S; Stotland P; Raphael S; Chow G; O'Brien CA; Cho C; Streutker C; Wong R; Schmocker S; Liberman S; Reinhold C; Kopek N; Marcus V; Bouchard A; Lavoie C; Morin S; Périgny M; Wright A; Neumann K; Clarke S; Patil NG; Arnason T; Williams L; McLeod R; Brown G; Mathieson A; Pooni A; Baxter NN
    JAMA Oncol; 2019 Jul; 5(7):961-966. PubMed ID: 30973610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 39. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data.
    Yeo DM; Oh SN; Lee MA; Lee IK; Lee YS; Oh ST; Lee SH; Park MS; Yim HW
    Eur Radiol; 2021 Nov; 31(11):8586-8596. PubMed ID: 33945023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.